Oestrogen and progesterone receptors in breast cancer: Past, present and future

Histopathology

Volumn 38, Issue 3, 2001, Pages 271-274

  Barnes, D M ^a   Hanby, A M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; DEXTRAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

ACCURACY; BREAST CANCER; CLINICAL TRIAL; CYTOSOL; DEVICE; ENZYME IMMUNOASSAY; FROZEN SECTION; HORMONE SENSITIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAL RESEARCH; METASTASIS; NOTE; OBSERVER VARIATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUALITY CONTROL; RECEPTOR BINDING; REFERENCE VALUE; SCORING SYSTEM; STAINING; VALIDATION PROCESS;

BREAST NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; FORECASTING; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IMMUNOHISTOCHEMISTRY; QUALITY CONTROL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034817697     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01060.x     Document Type: Note

References (38)

1. The comparison
2. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: Comparison with biochemical determination in a prospective study of 793 cases
3. On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases
4. Fate of steroid estrogens in target tissues
5. Estrogen receptors and breast cancer response to adrenalectomy
6. Steroid hormone binding and hormone receptors
7. Specific estrogen binding by the cytoplasm of human breast carcinoma
8. Two methods for measurement of oestradiol-17β and progesterone receptors in human breast cancer and correlation with response to treatment
9. Monoclonal antibodies to human estrogen receptor
10. Immunologic analysis of human breast cancer progesterone receptors. 1. Immuno-affinity purification of transformed receptors and production of monoclonal antibodies
11. The estrogen-receptor immuoassay in the prognosis and treatment of breast cancer
12. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumours
13. Methodology of immunohistochemical detection of oestrogen receptor in human breast carcinoma in formalin-fixed paraffin-embedded tissue: A comparison with frozen section methodology
14. Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment
15. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
16. Standardisation of steroid hormone receptor assays in human breast cancer. I. Reproducibility of oestradiol and progesterone receptor assays
17. EORTC receptor study group report: Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories
18. The reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: Inter-laboratory variance in the sensitivity of detection and evaluation of scoring systems
19. Immunohistochemical detection of steroid receptors in breast cancer: A working protocol
20. Biological markers maintaining standards
21. Comparative genomic hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer
22. P-cadherin expression in breast carcinoma indicates poor survival
23. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth
24. Immunophenotypic propoerties and estrogen dependency of budding cell structures in the developing mouse mammary gland
25. Estrogen receptors and breast cancer response to adrenalectomy
26. A new anti-oestrogenic agent in late breast cancer: An early clinical appraisal of ICI 46,474
27. Tamoxifen: An overview of recent studies in the file of oncology
28. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: The need for quality assurance
29. Predicting response to endocrine therapy in human breast cancer: A hypothesis
30. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
31. Tamoxifen for early breast cancer: An overview of the randomised trials
32. Oestrogen receptors and breast cancer
33. Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate and fluorouracil for breast cancer
34. The effect of c-erbB2 and oestrogen receptor status on survival of women with primary breast cancer treated with adjuvant CMF
35. Sudden fall in breast cancer death rates in England and Wales
36. UK and USA breast cancer deaths down 25% in year at ages 20-69 years
37. Response of metastatic breast cancer to trastuzumab?